BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anjana RM, Kesavadev J, Neeta D, Tiwaskar M, Pradeepa R, Jebarani S, Thangamani S, Sastry NG, Brijendra Kumar S, Ramu M, Gupta PPK, Vignesh J, Chandru S, Kayalvizhi S, Jagdish PS, Uthra SCB, Lovelena M, Jyoti S, Suguna Priya S, Kannan A, Mohan V, Unnikrishnan R. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes. Diabetes Technology & Therapeutics 2017;19:533-40. [DOI: 10.1089/dia.2017.0063] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Park C, Le QA. The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis. Diabetes Technol Ther 2018;20:613-21. [PMID: 30095980 DOI: 10.1089/dia.2018.0177] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
2 Varghese JS, Ho JC, Anjana RM, Pradeepa R, Patel SA, Jebarani S, Baskar V, Narayan KMV, Mohan V. Profiles of Intraday Glucose in Type 2 Diabetes and Their Association with Complications: An Analysis of Continuous Glucose Monitoring Data. Diabetes Technol Ther 2021;23:555-64. [PMID: 33720761 DOI: 10.1089/dia.2020.0672] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol 2020;8:17-26. [PMID: 31862147 DOI: 10.1016/S2213-8587(19)30385-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
4 Hallström S, Hirsch IB, Ekelund M, Sofizadeh S, Albrektsson H, Dahlqvist S, Svensson A, Lind M. Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections. Diabetes Technology & Therapeutics 2021;23:425-33. [DOI: 10.1089/dia.2020.0577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alhodaib HI, Alsulihem S. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia. World J Diabetes 2021; 12(11): 1908-1916 [PMID: 34888015 DOI: 10.4239/wjd.v12.i11.1908] [Reference Citation Analysis]
6 Price C, Ditton G, Russell GB, Aloi J. Reliability of Inpatient CGM: Comparison to Standard of Care. J Diabetes Sci Technol 2021;:19322968211062168. [PMID: 34911384 DOI: 10.1177/19322968211062168] [Reference Citation Analysis]
7 Deeb A, Muammar T, Alsaffar H, Sedaghat S, Al Hassani N, Odeh R, Alkhayyat H, Al Sinani A, Attia N, Adhami S, Elbarbary N. Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes. Diabetes Res Clin Pract 2021;173:108671. [PMID: 33493578 DOI: 10.1016/j.diabres.2021.108671] [Reference Citation Analysis]